Senti Biosciences (SNTI) Institutional Ownership $2.33 +0.08 (+3.56%) (As of 11/14/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Senti Biosciences (NASDAQ:SNTI)CurrentInstitutional OwnershipPercentage25.73%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$17.70MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$8.47M Get SNTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Senti Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNTI Institutional Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Senti Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/7/2024 8VC GP I LLC253,755$573K0.8%-90.0%5.541% 10/31/2024 ARK Investment Management LLC176,666$399K0.0%-88.9%3.858% 7/26/2024 ARK Investment Management LLC1,585,772$438K0.0%-2.8%34.624% 2/12/2024 8VC GP I LLC2,537,558$1.68M1.7%N/A5.697% 1/17/2024 ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423% 10/27/2023 TD Asset Management Inc241,208$102K0.0%+88.4%0.542% 9/7/2023Triatomic Management LP300,533$188K0.2%+42.5%0.675% 7/10/2023 ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143% 5/3/2023Triatomic Management LP210,883$249K0.2%+39.0%0.477% 4/17/2023 ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305% 2/14/2023Triatomic Management LP151,675$214K0.2%+168.7%0.346% 2/13/2023Artal Group S.A.55,555$78K0.0%-94.7%0.127% 2/7/2023 TD Asset Management Inc118,292$167K0.0%-12.3%0.270% 1/24/2023 ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391% 11/15/2022Triatomic Management LP56,454$123K0.1%N/A0.129% 11/7/2022 TD Asset Management Inc.134,892$285K0.0%+53.8%0.308% 11/3/2022The Manufacturers Life Insurance Company117,707$248K0.0%N/A0.269% 10/17/2022 ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771% 8/11/2022Artal Group S.A.1,055,555$2.07M0.1%N/A4.450% 8/8/2022 Allen Operations LLC21,443$42K0.0%N/A0.090% 8/4/2022 TD Asset Management Inc.87,696$172K0.0%N/A0.370% 7/29/2022Kingfisher Capital LLC113,163$222K0.1%N/A0.477% (Data available from 1/1/2016 forward) SNTI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNTI shares? During the previous two years, the following institutional investors and hedge funds held shares of Senti Biosciences shares: 8VC GP I LLC ($573K), ARK Investment Management LLC ($399K), Triatomic Management LP ($188K), and TD Asset Management Inc ($102K), Artal Group S.A. ($78K).Learn more on SNTI's institutional investors. What percentage of Senti Biosciences stock is owned by institutional investors? 25.73% of Senti Biosciences stock is owned by institutional investors. Learn more on SNTI's institutional investor holdings. Which institutional investors have been buying Senti Biosciences stock? The following institutional investors have purchased Senti Biosciences stock in the last 24 months: 8VC GP I LLC ($2.54M), Triatomic Management LP ($300.53K), ARK Investment Management LLC ($143.79K), and TD Asset Management Inc ($113.17K). How much institutional buying is happening at Senti Biosciences? Institutional investors have bought a total of 3,095,048 shares in the last 24 months. This purchase volume represents approximately $21.99M in transactions. Which Senti Biosciences major shareholders have been selling company stock? The following institutional investors have sold Senti Biosciences stock in the last 24 months: 8VC GP I LLC ($2.28M), ARK Investment Management LLC ($1.71M), Artal Group S.A. ($1M), and TD Asset Management Inc ($16.60K). How much institutional selling is happening at Senti Biosciences? Institutional investors have sold a total of 5,012,540 shares in the last 24 months. This volume of shares sold represents approximately $25.82M in transactions. Related Companies ProPhase Labs Major Shareholders Clene Major Shareholders Passage Bio Major Shareholders CalciMedica Major Shareholders NextCure Major Shareholders Lumos Pharma Major Shareholders Lexaria Bioscience Major Shareholders Lantern Pharma Major Shareholders Surrozen Major Shareholders BioLineRx Major Shareholders This page (NASDAQ:SNTI) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
